STING1 and neoplasm: Overall, the D/G@PFc nanoreactors are able to suppress both primary and metastatic tumors through a combination of chemodynamic therapy (CDT), the reversal of the immunosuppressive tumor microenvironment, and the activation of the STING pathway.